This topic contains a solution. Click here to go to the answer

Author Question: A key factor in experimental design is the A) testing of the effects of the dependent variable on ... (Read 32 times)

ashley

  • Hero Member
  • *****
  • Posts: 584
A key factor in experimental design is the
 
  A) testing of the effects of the dependent variable on the independent variable.
  B) protection of internal validity by controls to reduce confounding.
  C) protection of statistical validity by controls to reduce confounding.
  D) demonstration of a systematic, but not causal, relationship between two variables.

Question 2

The careful arrangements of all parts of an experiment so as to test the effects of the independent variable on the dependent variable while protecting against threats to internal validity is called
 
  A) matched design.
  B) hypothesis testing.
  C) experimental design.
  D) hypothesis experimental design.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jody Vaughn

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C





 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library